These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37741521)

  • 1. Sensitivity and Specificity of a Neuropathic Screening Tool (Self-Report Leeds Assessment of Neuropathic Symptoms and Signs, S-LANSS) in Adolescents With Moderate-Severe Chronic Pain.
    Walker SM; Peters J; Verriotis M; Farag F; Jay MA; Howard RF
    J Pain; 2024 Feb; 25(2):451-465. PubMed ID: 37741521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translation, Cultural Adaptation, and Validation of Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) and Self-Complete Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) Questionnaires into the Greek Language.
    Batistaki C; Lyrakos G; Drachtidi K; Stamatiou G; Kitsou MC; Kostopanagiotou G
    Pain Pract; 2016 Jun; 16(5):552-64. PubMed ID: 25880345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research.
    Bennett MI; Smith BH; Torrance N; Potter J
    J Pain; 2005 Mar; 6(3):149-58. PubMed ID: 15772908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of self report version of the Leeds Assessment of Neuropathic Symptoms and Signs score for identification of neuropathic pain in patients from northern Turkey.
    Türkel Y; Türker H; Demir IA; Bayrak AO; Onar MK
    Adv Clin Exp Med; 2014; 23(4):599-603. PubMed ID: 25166445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity and reliability of the Spanish-language version of the self-administered Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) pain scale.
    López-de-Uralde-Villanueva I; Gil-Martínez A; Candelas-Fernández P; de Andrés-Ares J; Beltrán-Alacreu H; La Touche R
    Neurologia (Engl Ed); 2018 Oct; 33(8):505-514. PubMed ID: 27939112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of painDETECT and S-LANSS in identifying the neuropathic component of mixed pain among patients with tumor-related cancer pain.
    Higashibata T; Tagami K; Miura T; Okizaki A; Watanabe YS; Matsumoto Y; Morita T; Kinoshita H
    Support Care Cancer; 2020 Jan; 28(1):279-285. PubMed ID: 31041583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of S-LANSS, a tool for screening neuropathic pain, for predicting postherpetic neuralgia in patients after acute herpes zoster events: a single-center, 12-month, prospective cohort study.
    Cho SI; Lee CH; Park GH; Park CW; Kim HO
    J Pain; 2014 Feb; 15(2):149-56. PubMed ID: 24342706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agreement and correlation between the self-report leeds assessment of neuropathic symptoms and signs and Douleur Neuropathique 4 Questions neuropathic pain screening tools in subjects with low back-related leg pain.
    Walsh J; Rabey MI; Hall TM
    J Manipulative Physiol Ther; 2012; 35(3):196-202. PubMed ID: 22397741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity and reliability of the Turkish Self-administered Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) questionnaire.
    Koc R; Erdemoglu AK
    Pain Med; 2010 Jul; 11(7):1107-14. PubMed ID: 20456071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the S-LANSS in the community setting.
    Weingarten TN; Watson JC; Hooten WM; Wollan PC; Melton LJ; Locketz AJ; Wong GY; Yawn BP
    Pain; 2007 Nov; 132(1-2):189-94. PubMed ID: 17869424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pain phenotype in patients with knee osteoarthritis: classification and measurement properties of painDETECT and self-report Leeds assessment of neuropathic symptoms and signs scale in a cross-sectional study.
    Moreton BJ; Tew V; das Nair R; Wheeler M; Walsh DA; Lincoln NB
    Arthritis Care Res (Hoboken); 2015 Apr; 67(4):519-28. PubMed ID: 25155472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) questionnaire and its correlation with visual analog pain scales in Greek population.
    Spanos K; Lachanas VA; Chan P; Bargiota A; Giannoukas AD
    J Diabetes Complications; 2015; 29(8):1142-5. PubMed ID: 26345340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-Cultural Psychometric Assessment of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) Pain Scale in the Portuguese Population.
    Barbosa M; Bennett MI; Verissimo R; Carvalho D
    Pain Pract; 2014 Sep; 14(7):620-4. PubMed ID: 24289475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translation and linguistic validation of the self-completed Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) scale for use in a Libyan population.
    Elzahaf RA; Tashani OA; Unsworth BA; Johnson MI
    Pain Pract; 2013 Mar; 13(3):198-205. PubMed ID: 22726274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying neuropathic pain in patients with head and neck cancer: use of the Leeds Assessment of Neuropathic Symptoms and Signs Scale.
    Potter J; Higginson IJ; Scadding JW; Quigley C
    J R Soc Med; 2003 Aug; 96(8):379-83. PubMed ID: 12893852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The Self -Complete of Leeds Assessment Neuropathic Symptoms and Signs: an attempt to adapt it for Polish population].
    Cnotliwy M; Jurewicz A; Gołąb -Janowska M; Kazimierczak A; Głazek W
    Pomeranian J Life Sci; 2016; 62(2):18-21. PubMed ID: 29537216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the Nepali Version of the Self-reported Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) in Adults With Chronic Pain and Predominantly Low-literacy Levels.
    Sharma S; Higgins C; Cameron P; Bimali I; Hales TG; Bennett MI; Colvin L; Smith BH
    J Pain; 2022 Mar; 23(3):424-433. PubMed ID: 34583020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can self-reported pain characteristics and bedside test be used for the assessment of pain mechanisms? An analysis of results of neuropathic pain questionnaires and quantitative sensory testing.
    Gierthmühlen J; Schneider U; Seemann M; Freitag-Wolf S; Maihöfner C; Enax-Krumova EK; Azad SC; Üçeyler N; Birklein F; Maier C; Tölle T; Treede RD; Baron R
    Pain; 2019 Sep; 160(9):2093-2104. PubMed ID: 31162335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of the DN4, S-LANSS, and painDETECT screening questionnaires to detect the neuropathic pain components in people with acute whiplash-associated disorders: a cross-sectional study.
    Ríos-León M; Taylor J; Segura-Fragoso A; Barriga-Martín A
    Pain Med; 2024 May; 25(5):344-351. PubMed ID: 38150190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for neuropathic characteristics in failed back surgery syndromes: challenges for guiding treatment.
    Markman JD; Kress BT; Frazer M; Hanson R; Kogan V; Huang JH
    Pain Med; 2015 Mar; 16(3):520-30. PubMed ID: 25530081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.